GIM
DVAX

Glenmede Investment Management’s Dynavax Technologies DVAX Stock Holding History

Glenmede Investment Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12.6M Buy
1,264,369
+243,240
+24% +$2.53M 0.06% 294
2025
Q2 		$10.1M Buy
+1,021,129
New +$10.8M 0.05% 350

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Glenmede Investment Management's DVAX Position: Q3 2025 in Review

Glenmede Investment Management increased its Dynavax Technologies (DVAX) stake by 24% in Q3 2025, buying an estimated $2.53M and bringing the position to 1,264,369 shares worth $12.6M. The position accounts for 0.06% of the portfolio, ranked #294.

Glenmede Investment Management first reported a position in DVAX in Q2 2025 and has held it in 2 quarters since. 270 funds tracked by Wall St. Rank hold DVAX as of Q3 2025.

  • Glenmede Investment Management held 1,264,369 shares of Dynavax Technologies worth $12.6M as of Q3 2025.
  • Glenmede Investment Management bought 243,240 Dynavax Technologies shares in Q3 2025, an estimated $2.53M.
  • Dynavax Technologies made up 0.06% of Glenmede Investment Management's portfolio in Q3 2025, its #294 holding.
  • Glenmede Investment Management first reported a position in Dynavax Technologies in Q2 2025 and has held it in 2 quarters since.
  • 270 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.